AbbVie Inc (ABBV)

Days of sales outstanding (DSO)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
DSO	days	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —

The days of sales outstanding (DSO) for AbbVie Inc as per the provided data are not available for the periods from March 31, 2020, to December 31, 2024. DSO is a financial ratio that indicates the average number of days it takes a company to collect payment after a sale has been made.

Given the absence of specific DSO figures in the data provided, it is challenging to assess AbbVie's efficiency in collecting accounts receivable and managing its working capital. However, typically a lower DSO figure is favorable as it signifies quicker collection of sales, better cash flow management, and potentially a healthier liquidity position.

Without the DSO values, it is not feasible to determine the trend of AbbVie's collection efficiency over time or compare it with industry benchmarks or historical performance. Monitoring DSO regularly helps assess a company's credit policies, customer payment behaviors, and overall financial health. For a more in-depth analysis, it would be necessary to have access to the specific DSO data points for AbbVie Inc's financial periods.